Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 186

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases

Open access
Sarkar, Monika, Brady, Carla W., Fleckenstein, Jaquelyn, Forde, Kimberly A., Khungar, Vandana, Molleston, Jean P., Afshar, Yalda, Terrault, Norah A.·2021·Hepatology

Abstract

Purpose and Scope of the GuidanceThis first Practice Guidance on Reproductive Health from the American Association for the Study of Liver Diseases (AASLD) is intended to be a comprehensive reference on adolescents and adults with chronic liver disease.The Guidance specifically (1) addresses management of reproductive health in women and men from puberty to senescence and (2) summarizes the natural history, risk factors, evaluation, and optimal management of liver diseases during pregnancy and after delivery.Intended for use by health care providers, this Guidance identifies preferred approaches to diagnostic, therapeutic, and preventive aspects of reproductive health.It should not replace clinical judgment for a unique patient, but instead provide general guidance to optimize the care of most patients.A critical aspect of reproductive care in patients with liver disease is the need for close collaboration among hepatologists, maternal-fetal medicine (MFM) specialists, and pediatricians.Whether for preconception counseling, assisted reproduction, pregnancy, or postpartum care, a multidisciplinary approach is advised to help yield the best outcomes.This AASLD Guidance provides a data-supported approach to the management of reproductive health in patients with liver disease.It differs from AASLD Guidelines, which are supported by systematic reviews of the literature, formal rating of the quality of the evidence and strength of the recommendations, and, if appropriate, meta-analysis of results using the Grading of Recommendations Assessment, Development, and Evaluation system.In contrast, this Guidance was developed by consensus of an expert panel and provides guidance statements based on formal review and analysis of the literature on the topics, with oversight provided by the AASLD Practice Guidelines Committee at all stages of Guidance development.The Committee chose to perform a Guidance on this topic because a sufficient number of randomized controlled trials were not available to support the development of a meaningful Guideline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31559

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 186

Metadata

Authors
Sarkar, M., Brady, C. W., Fleckenstein, J., Forde, K. A., Khungar, V., Molleston, J. P., Afshar, Y., & Terrault, N. A.
Venue
Hepatology
Published
2021-01
Volume
73
Issue
1
Pages
318-365
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W3087419935
Cited by
186
References
19
FWCI
7.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. https://app.cochat.ai/papers/10.1002/hep.31559
The paper
Sarkar, M., Brady, C. W., Fleckenstein, J., Forde, K. A., Khungar, V., Molleston, J. P., Afshar, Y., & Terrault, N. A. (2021). Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. https://doi.org/10.1002/hep.31559

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.